JP2009533367A5 - - Google Patents

Download PDF

Info

Publication number
JP2009533367A5
JP2009533367A5 JP2009504628A JP2009504628A JP2009533367A5 JP 2009533367 A5 JP2009533367 A5 JP 2009533367A5 JP 2009504628 A JP2009504628 A JP 2009504628A JP 2009504628 A JP2009504628 A JP 2009504628A JP 2009533367 A5 JP2009533367 A5 JP 2009533367A5
Authority
JP
Japan
Prior art keywords
antibody
antibody according
amount
less
acc2795
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009504628A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009533367A (ja
JP4718634B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/003165 external-priority patent/WO2007115814A2/en
Publication of JP2009533367A publication Critical patent/JP2009533367A/ja
Publication of JP2009533367A5 publication Critical patent/JP2009533367A5/ja
Application granted granted Critical
Publication of JP4718634B2 publication Critical patent/JP4718634B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009504628A 2006-04-11 2007-04-10 インスリン様増殖因子i受容体及びその使用 Active JP4718634B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06007571.0 2006-04-11
EP06007571 2006-04-11
PCT/EP2007/003165 WO2007115814A2 (en) 2006-04-11 2007-04-10 Antibodies against insulin-like growth factor i receptor and uses thereof

Publications (3)

Publication Number Publication Date
JP2009533367A JP2009533367A (ja) 2009-09-17
JP2009533367A5 true JP2009533367A5 (cg-RX-API-DMAC7.html) 2010-11-11
JP4718634B2 JP4718634B2 (ja) 2011-07-06

Family

ID=36940705

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009504628A Active JP4718634B2 (ja) 2006-04-11 2007-04-10 インスリン様増殖因子i受容体及びその使用

Country Status (20)

Country Link
US (1) US20080014203A1 (cg-RX-API-DMAC7.html)
EP (2) EP2363417A1 (cg-RX-API-DMAC7.html)
JP (1) JP4718634B2 (cg-RX-API-DMAC7.html)
KR (2) KR20120028396A (cg-RX-API-DMAC7.html)
CN (1) CN101421305B (cg-RX-API-DMAC7.html)
AR (1) AR060592A1 (cg-RX-API-DMAC7.html)
AU (1) AU2007236199B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0710185B8 (cg-RX-API-DMAC7.html)
CA (2) CA2647181C (cg-RX-API-DMAC7.html)
CR (1) CR10301A (cg-RX-API-DMAC7.html)
EC (1) ECSP088816A (cg-RX-API-DMAC7.html)
ES (1) ES2403075T3 (cg-RX-API-DMAC7.html)
IL (1) IL194397A (cg-RX-API-DMAC7.html)
MX (1) MX2008012950A (cg-RX-API-DMAC7.html)
NO (1) NO20084082L (cg-RX-API-DMAC7.html)
NZ (1) NZ571414A (cg-RX-API-DMAC7.html)
RU (1) RU2541765C2 (cg-RX-API-DMAC7.html)
UA (1) UA95284C2 (cg-RX-API-DMAC7.html)
WO (1) WO2007115814A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200808597B (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7846724B2 (en) 2006-04-11 2010-12-07 Hoffmann-La Roche Inc. Method for selecting CHO cell for production of glycosylated antibodies
AR064464A1 (es) * 2006-12-22 2009-04-01 Genentech Inc Anticuerpos anti - receptor del factor de crecimiento insulinico
PE20090368A1 (es) 2007-06-19 2009-04-28 Boehringer Ingelheim Int Anticuerpos anti-igf
CN101903401B (zh) 2007-12-21 2013-06-05 罗切格利卡特公司 抗体的稳定性试验
PT2376116E (pt) 2008-12-12 2016-02-24 Boehringer Ingelheim Int Anticorpos anti-igf
WO2010112194A1 (en) * 2009-04-02 2010-10-07 F. Hoffmann-La Roche Ag Antigen-binding polypeptides and multispecific antibodies comprising them
US20100316639A1 (en) 2009-06-16 2010-12-16 Genentech, Inc. Biomarkers for igf-1r inhibitor therapy
EP2456547B2 (en) 2009-07-24 2024-03-06 F. Hoffmann-La Roche AG Stirrer system
CA2774953A1 (en) * 2009-10-07 2011-04-14 The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services Human domain antibodies against components of the human insulin-like growth factor (igf) system
JP5711751B2 (ja) 2009-10-26 2015-05-07 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft グリコシル化された免疫グロブリンの調製方法
WO2011101328A2 (en) 2010-02-18 2011-08-25 Roche Glycart Ag Treatment with a humanized igg class anti egfr antibody and an antibody against insulin like growth factor 1 receptor
WO2011135040A1 (en) 2010-04-30 2011-11-03 F. Hoffmann-La Roche Ag Fluorescent antibody fusion protein, its production and use
MX342235B (es) 2010-11-05 2016-09-21 Hoffmann La Roche Metodo optimizado para captura de anticuerpo por cromatografia de modo mixto.
MX354663B (es) 2011-06-22 2018-03-14 Hoffmann La Roche Eliminación de células diana por parte de células t citotóxicas específicas de virus utilizando complejos que comprenden mhc de clase i.
RU2502798C2 (ru) * 2012-02-22 2013-12-27 Общество с ограниченной ответственностью "Фармако Биотех" КЛЕТОЧНАЯ ЛИНИЯ huFSHIK, СЕКРЕТИРУЮЩАЯ РЕКОМБИНАНТНЫЙ ЧЕЛОВЕЧЕСКИЙ ФСГ
WO2014067642A1 (en) 2012-11-05 2014-05-08 Mab Discovery Gmbh Method for the production of multispecific antibodies
EP2727941A1 (en) 2012-11-05 2014-05-07 MAB Discovery GmbH Method for the production of multispecific antibodies
RU2015129640A (ru) 2012-12-21 2017-01-26 Ф.Хоффманн-Ля Рош Аг Связанные дисульфидом мультивалентные многофункциональные белки, содержащие молекулы гкгс класса 1
US20140255413A1 (en) 2013-03-07 2014-09-11 Boehringer Ingelheim International Gmbh Combination therapy for neoplasia treatment
WO2021119234A1 (en) * 2019-12-10 2021-06-17 Horizon Pharma Ireland Ltd. Glycosylated antibodies against insulin-like growth factor i receptor and uses thereof
CN119792512A (zh) 2020-10-14 2025-04-11 维里迪安治疗公司 用于治疗甲状腺眼病的组合物和方法
US20230084477A1 (en) 2021-08-10 2023-03-16 Viridian Therapeutics, Inc. Compositions, doses, and methods for treatment of thyroid eye disease

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675187A (en) 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
US5202238A (en) * 1987-10-27 1993-04-13 Oncogen Production of chimeric antibodies by homologous recombination
US5204244A (en) * 1987-10-27 1993-04-20 Oncogen Production of chimeric antibodies by homologous recombination
US5770429A (en) * 1990-08-29 1998-06-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
GB9022543D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Antibody production
US5650508A (en) * 1991-12-27 1997-07-22 Georgia Tech Research Corporation Peptide ketoamides
DE69329503T2 (de) 1992-11-13 2001-05-03 Idec Pharma Corp Therapeutische Verwendung von chimerischen und markierten Antikörpern, die gegen ein Differenzierung-Antigen gerichtet sind, dessen Expression auf menschliche B Lymphozyt beschränkt ist, für die Behandlung von B-Zell-Lymphoma
PT1176195E (pt) * 1999-04-09 2013-07-18 Kyowa Hakko Kirin Co Ltd Processo para controlar a actividade de uma molécula funcional sob o ponto de vista imunológico
US20030165502A1 (en) * 2000-06-13 2003-09-04 City Of Hope Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth
US7241444B2 (en) * 2002-01-18 2007-07-10 Pierre Fabre Medicament Anti-IGF-IR antibodies and uses thereof
US7553485B2 (en) * 2002-01-18 2009-06-30 Pierre Fabre Medicament Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
NZ571508A (en) * 2002-05-24 2010-05-28 Schering Corp Neutralizing human anti-IGFR antibody
ES2383014T3 (es) * 2003-04-02 2012-06-15 F. Hoffmann-La Roche Ag Anticuerpos contra el factor I de crecimiento similar a insulina y usos de los mismos
AR046071A1 (es) * 2003-07-10 2005-11-23 Hoffmann La Roche Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos
JPWO2005014651A1 (ja) * 2003-08-11 2006-11-24 中外製薬株式会社 糖鎖改変抗hm1.24抗体
WO2005034994A1 (ja) * 2003-10-10 2005-04-21 Chugai Seiyaku Kabushiki Kaisha 固形腫瘍治療剤

Similar Documents

Publication Publication Date Title
JP2009533367A5 (cg-RX-API-DMAC7.html)
TWI780083B (zh) 抗pd-1抗體及組成物
AU2013229786B2 (en) Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof
JP6282745B2 (ja) 修飾抗上皮成長因子受容体抗体およびその使用法
JP7745113B2 (ja) 多重特異性抗体およびその使用
JP2009114201A5 (cg-RX-API-DMAC7.html)
JP2017071606A5 (cg-RX-API-DMAC7.html)
JP2009532336A5 (cg-RX-API-DMAC7.html)
JP2014533279A5 (cg-RX-API-DMAC7.html)
PT2576618T (pt) Anticorpos contra gdf8 humano
WO2017161206A1 (en) Conjugates containing conditionally active antibodies or antigen-binding fragments thereof, and methods of use
JP2019527194A5 (cg-RX-API-DMAC7.html)
JP2015533781A5 (cg-RX-API-DMAC7.html)
KR20200013231A (ko) 항암 조합 요법
CA3158579A1 (en) Heavy chain antibodies binding to cd38
JP2018512402A5 (cg-RX-API-DMAC7.html)
JP2020527152A5 (cg-RX-API-DMAC7.html)
WO2018183366A1 (en) Combination therapies of csf-1r or csf-1 antibodies and a t-cell engaging therapy
TW202124432A (zh) 使用pd-1軸抑制劑及抗骨膜蛋白抗體治療癌症之方法
US20250257141A1 (en) Combination therapy for the treatment of cancer comprising a fas axis antagonist and a t-reg cell depleting agent antagonist
JP7668943B2 (ja) 多重特異性抗体およびその使用
US20220218838A1 (en) Adc for a treatment concomitant with or subsequent to docetaxel
WO2025072516A1 (en) Methods of reducing weight loss using anti-gdf15 antibodies
JP2025036273A (ja) 多重特異性抗体およびその使用
CN118946583A (zh) 用t细胞接合分子治疗前列腺癌的联合治疗方法